2016 AAFP Guidelines for the Management of Feline Hyperthyroidism.

Area of Science:

• Veterinary Medicine
• Internal Medicine
• Endocrinology

Background:

• Feline hyperthyroidism (FHT) has evolved from a rare condition treated by specialists to a common disease managed in primary care settings.
• Early diagnosis of FHT is now possible through routine senior wellness panels and diagnostic work-ups, identifying the disease before classic clinical signs manifest.
• Earlier diagnosis raises critical questions regarding the health significance of early presentations, optimal timing for treatment initiation, and management of comorbidities.

Purpose of the Study:

• To provide primary care veterinarians with evidence-based guidelines for the diagnosis and management of feline hyperthyroidism (FHT).
• To address key clinical questions concerning early disease recognition, treatment timing, and the management of concurrent conditions alongside FHT.
• To offer practical recommendations for testing, categorizing FHT cases, and selecting appropriate treatment strategies.

Main Methods:

• Distillation of current research literature on FHT into practical recommendations for veterinary practitioners.
• Categorization of FHT diagnoses into six distinct clinical categories with associated management strategies.
• Emphasis on evidence-based approaches, supplemented by expert clinical experience where research consensus is lacking.

Main Results:

• Provides clear testing sequences to avoid misdiagnosis of FHT.
• Outlines treatment options for FHT and strategies for monitoring patients to prevent exacerbation of comorbid diseases.
• Offers an evidence-based narrative to guide veterinary teams in managing FHT and communicating with owners.

Conclusions:

• The 2016 AAFP Guidelines offer a comprehensive, evidence-based approach to managing feline hyperthyroidism for general practitioners.
• These guidelines aim to improve case outcomes by standardizing diagnostic and therapeutic approaches.
• The recommendations address the complexities of FHT management, including early intervention and concurrent disease management.